Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.6500
-0.0450 (-6.47%)
At close: Mar 28, 2025, 4:00 PM
0.6200
-0.0300 (-4.62%)
After-hours: Mar 28, 2025, 7:53 PM EST
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $12.56 million as of March 28, 2025. Its market cap has decreased by -43.92% in one year.
Market Cap
12.56M
Enterprise Value
19.68M
1-Year Change
-43.92%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $12.56M, a decrease of -95.42%. That is a compound annual growth rate of -59.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 12.56M | -43.48% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |